We are delighted that the great team at The Antibody Company has played such a vital role in developing a novel lateral flow device that tests for COVID-19 antibodies that is easily adaptable to mutations that arise in the virus. This important novel technology will be important in the fight against COVID-19.
- Rapid and competitive quotation
- Flexible project start and end points
- Experienced team and project management
- Real-time project updates and technical support
- No customs delays, no duty and overseas shipping for UK based companies
- Same day shipping
- Specialist problem solvers
De-risk promising early stage technology by using The Antibody Company's integrated research and production facilities and over 20 years' experience for developing diagnostics and therapeutics. Our Virtual Lab packages can speed up the process and save significant up-front expenditure on specialist equipment and staff.
We offer our Virtual Lab expertise for assistance and partnering in grant and commercial applications.
The Antibody Company offers competitive pricing for single phase or the entire process of generating high-quality monoclonal antibodies and assays.